Clinical Trial Update: Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on a therapy for pediatric relapsed or refractory acute lymphoblastic leukemia, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia, Lymphoma, Lymphoblastic | Phase 2 | Status: COMPLETED | Results posted: 2013-12-16